Publications

• Responders and non-responders to probiotic interventions: how can we improve the odds?

  Reid G, Gaudier E, Guarner F, Huffnagle GB, Macklaim J, Munoz AM, Martini M, Ringel-Kulka T, Sartor B, Unal R, Verbeke K, Walter J. 2010. Responders and non-responders to probiotic interventions: how can we improve the odds? Gut Microbes 1(3):1-5.

  
  

• Safety assessment of probiotics for human use

  Sanders ME, Akkermans LMA, Haller D, Hammerman C, Heimbach J, Huys G, Levy D, Mack D, Phothirath P, Constable A, Solano-Aguilar G, Vaughan E. 2010. Safety assessment of probiotics for human use. Gut Microbes 1 (3):1-22.

  
  

• No causal link between obesity and probiotics

  Delzenne N, Reid G. No causal link between obesity and probiotics. Nat Rev Microbiol. 2009 Dec;7(12):901

  
  

• Probiotic prophylaxis in predicted severe acute pancreatitis

  Reid G, Gibson G, Sanders ME, Guarner F, Versalovic J. 2008. Probiotic prophylaxis in predicted severe acute pancreatitis. The Lancet 372:112-113.

  
  

• Progress and challenges. International Dairy Journal

  Reid, G. 2008. Probiotics and prebiotics – Progress and challenges. International Dairy Journal, 18:969–975.

  
  

• A nonviable preparation of L. acidophilus is not a probiotic

  Sanders ME, Hamilton-Miller, J, Reid G, Gibson G. 2007. A nonviable preparation of L. acidophilus is not a probiotic. Clin Infect. Dis. 44:886.

  
  

• Probiotic and prebiotic influence beyond the intestinal tract

  Lenoir-Wijnkoop I, Sanders, M.E., Van Loo, J., Rayes, N., Timmerman, H., Sherman, P. Cabana, M., Corthier, G., Charbonneau, D., Vaneechoutte, M., Caglar, E., Wolvers, D., Manneck, I. 2007. Probiotic and prebiotic influence beyond the intestinal tract. Nutr Rev. 65:469-489.

  
  

• Mechanisms of disease: the hygiene hypothesis revisited

  Guarner F, Bourdet-Sicard R, Brandtzaeg P, Gill HS, McGuirk P, van Eden W, Versalovic J, Weinstock JV, Rook GA. 2006. Mechanisms of disease: the hygiene hypothesis revisited. Nat Clin Pract Gastroenterol Hepatol. 3(5):275-84.

  
  

• Use of genetically modified microbes for human health

  Reid G, Gibson GR, Gill HS, Klaenhammer TR, Rastall RA, Rowland I Sanders ME. 2006. Use of genetically modified microbes for human health. Microbial Ecol. Health Dis. 18: 75-76.

  
  

• Probiotics for the developing world

  Reid G, Anand S, Bingham MO, Mbugua G, Wadstrom T, Fuller R, Anukam K Katsivo M. 2005. Probiotics for the developing world. J Clin Gastroenterol. 39(6):485-8.

  
  

• Selected topics in probiotics and prebiotics: meeting report for the 2004 International Scientific Association for Probiotics and Prebiotics

  Sanders ME, Guarner F, Mills D, Pot B, Rafter J, Rastall R, Reid G, Ringel Y, Rowland I, Saarela M, Tuohy K. 2005. Selected topics in probiotics and prebiotics: meeting report for the 2004 International Scientific Association for Probiotics and Prebiotics. Cur Iss Intestinal Microbiol. 6: 55-68.

  
  

• Modulation of the microbial ecology of the human colon by probiotics, prebiotics and synbiotics to enhance human health: an overview of enabling science and potential applications.

  Rastall R, Gibson G, Gill H, Guarner F, Klaenhammer T, Pot B, Reid G, Rowland I, Sanders ME. 2005. Modulation of the microbial ecology of the human colon by probiotics, prebiotics and synbiotics to enhance human health: an overview of enabling science and potential applications. FEMS Microbial Ecology 52(2): 145-152.

  
  

• Weight of evidence needed to substantiate a health effect for probiotics and prebiotics: scientific and regulatory considerations in Canada, EU, and U.S. Eur

  Sanders ME, Tompkins T, Heimbach J, Kolida S. 2005. Weight of evidence needed to substantiate a health effect for probiotics and prebiotics: scientific and regulatory considerations in Canada, EU, and U.S. Eur J Nutr. 44(5):303-10.

  
  

• Objectives and activities of the International Scientific Association for Probiotics and Prebiotics

  Sanders ME. 2005. Objectives and activities of the International Scientific Association for Probiotics and Prebiotics. In, Cesare Schiavi (Ed.) Probiotics, Biotherapeutics & Health. Mofin Alce, Novara, Italy., p. 206-216.

  
  

• Discussion on toll-like receptor 9 signaling mediates the anti-inflammatory effects of probiotics in murine experimental colitis

  Reid G, Guarner F, Gibson G, Tompkins T, Gill H, Rowland I, Rastall B, Pot B, Sanders ME. 2004. Discussion on toll-like receptor 9 signaling mediates the anti-inflammatory effects of probiotics in murine experimental colitis. Gastroenterology. 127:366-7.

  
  

• D(-)-lactic acid producing probiotics, d(-)-lactic acidosis and infants

  Mack D. 2004. D(-)-lactic acid producing probiotics, d(-)-lactic acidosis and infants. Canadian J Gastroenterol. 18:671-5.

  
  

• Good intentions, poor study design

  Tompkins TA, Sanders ME. 2004. Good intentions, poor study design. Can Fam Physician. 50:1499-500.

  
  

• New scientific paradigms for probiotics and prebiotics

  Reid G., Sanders ME, Gaskins HR, Gibson GR, Mercenier A, Rastall R, Roberfroid M, Rowland I, Cherbut C, Klaenhammer T R. 2003. New scientific paradigms for probiotics and prebiotics. J Clin Gastroenterol. 37:105-118.

  
  

• Credibility for probiotics

  Credibility for probiotics. ISAPP supports research investigating beneficial microorganisms. California Dairy Dispatch. Vol. 12(2), Fall 2002.

  
  

• Much ferment on the probiotics front

  Ferber D. 2002. Much ferment on the probiotics front. ASM News. 68:369-370.

  
  

« 1 2 3 4